Cargando…
Non-vitamin K antagonist oral anticoagulants in adults with a Fontan circulation: are they safe
BACKGROUND: In Fontan patients with atrial arrhythmias (AA), non-vitamin K antagonist oral anticoagulants(NOACs) have a class III recommendation according to the Pediatric & Congenital Electrophysiology Society (PACES)/Heart Rhythm Society (HRS) guideline in 2014, due to lack of data on outcomes...
Autores principales: | Yang, Hayang, Veldtman, Gruschen R, Bouma, Berto J, Budts, Werner, Niwa, Koichiro, Meijboom, Folkert, Scognamiglio, Giancarlo, Egbe, Alexander Chima, Schwerzmann, Markus, Broberg, Craig, Morissens, Marielle, Buber, Jonathan, Tsai, Shane, Polyzois, Ioannis, Post, Martijn C, Greutmann, Matthias, Van Dijk, Arie, Mulder, Barbara JM, Aboulhosn, Jamil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6560660/ https://www.ncbi.nlm.nih.gov/pubmed/31245011 http://dx.doi.org/10.1136/openhrt-2018-000985 |
Ejemplares similares
-
Prognostic power of cardiopulmonary exercise testing in Fontan patients: a systematic review
por: Udholm, Sebastian, et al.
Publicado: (2018) -
Risk stratification of adults with congenital heart disease during the COVID-19 pandemic: insights from a multinational survey among European experts
por: Ruperti-Repilado, Francisco Javier, et al.
Publicado: (2021) -
Clinical outcome of COVID-19 in patients with adult congenital heart disease
por: Schwerzmann, Markus, et al.
Publicado: (2021) -
Myocardial fibrosis, diastolic dysfunction and elevated liver stiffness in the Fontan circulation
por: Alsaied, Tarek, et al.
Publicado: (2020) -
Atrial arrhythmias and thromboembolic complications in adults post Fontan surgery
por: Wan, Darryl, et al.
Publicado: (2020)